agilon health (AGL)
agilon health on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as services-misc health & allied services, nec.
1.0M
Short interest
settlement 2026-09-30
3.8
Days to cover
-2.4 days vs prior
68.4%
Short share of volume
2026-10-23
8
Fails to deliver
settlement 2026-09-30
Tue 3 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-23.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in AGL is 1,008,702 shares, down 71,822 shares over the last month. Over the last 48 readings it ranged from 632,194 shares (29 May 2026) to 36,223,247 shares (31 October 2024). The latest reading sits at the bottom of that range. At the reported average volume of 263K shares a day that is 3.8 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/agl" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 1,008,702 | -4.0% | 262,672 | 3.84 |
| 2026-09-15 | 1,050,591 | -2.8% | 168,541 | 6.23 |
| 2026-08-31 | 1,080,524 | +10.4% | 235,499 | 4.59 |
| 2026-08-14 | 978,825 | +12.2% | 502,851 | 1.95 |
| 2026-07-31 | 872,239 | +1.5% | 327,103 | 2.67 |
| 2026-07-15 | 859,438 | +18.8% | 275,154 | 3.12 |
| 2026-06-30 | 723,167 | +11.7% | 386,125 | 1.87 |
| 2026-06-15 | 647,369 | +2.4% | 259,948 | 2.49 |
| 2026-05-29 | 632,194 | -1.2% | 306,473 | 2.06 |
| 2026-05-15 | 639,741 | -19.2% | 800,386 | 1.00 |
| 2026-04-30 | 791,524 | -20.9% | 427,840 | 1.85 |
| 2026-04-15 | 1,000,735 | -26.3% | 438,914 | 2.28 |
| 2026-03-31 | 1,357,594 | -94.9% | 191,813 | 7.08 |
| 2026-03-13 | 26,654,381 | +8.4% | 4,944,458 | 5.39 |
| 2026-02-27 | 24,591,484 | +20.5% | 7,495,718 | 3.28 |
| 2026-02-13 | 20,413,986 | +1.2% | 11,060,283 | 1.85 |
| 2026-01-30 | 20,177,282 | -1.1% | 5,833,596 | 3.46 |
| 2026-01-15 | 20,406,494 | +5.2% | 6,965,020 | 2.93 |
| 2025-12-31 | 19,389,860 | -6.1% | 4,767,485 | 4.07 |
| 2025-12-15 | 20,639,623 | +15.1% | 8,773,443 | 2.35 |
| 2025-11-28 | 17,931,905 | -13.8% | 12,856,772 | 1.39 |
| 2025-11-14 | 20,803,215 | -0.4% | 14,691,806 | 1.42 |
| 2025-10-31 | 20,881,325 | +2.4% | 6,796,676 | 3.07 |
| 2025-10-15 | 20,402,280 | +3.1% | 7,275,743 | 2.80 |
| 2025-09-30 | 19,794,355 | -13.2% | 6,794,462 | 2.91 |
| 2025-09-15 | 22,792,150 | +25.4% | 6,784,631 | 3.36 |
| 2025-08-29 | 18,167,816 | -5.0% | 6,529,773 | 2.78 |
| 2025-08-15 | 19,114,563 | +1.0% | 36,187,365 | 1.00 |
| 2025-07-31 | 18,921,380 | +6.2% | 2,814,866 | 6.72 |
| 2025-07-15 | 17,820,027 | -14.5% | 2,759,549 | 6.46 |
| 2025-06-30 | 20,836,728 | -1.9% | 3,588,333 | 5.81 |
| 2025-06-13 | 21,228,626 | +5.8% | 3,528,842 | 6.02 |
| 2025-05-30 | 20,070,003 | -9.6% | 5,182,499 | 3.87 |
| 2025-05-15 | 22,198,808 | +1.1% | 5,368,487 | 4.14 |
| 2025-04-30 | 21,955,559 | +14.8% | 7,057,884 | 3.11 |
| 2025-04-15 | 19,126,130 | +4.7% | 6,416,456 | 2.98 |
| 2025-03-31 | 18,269,995 | -1.6% | 4,871,450 | 3.75 |
| 2025-03-14 | 18,562,520 | +10.4% | 6,579,962 | 2.82 |
| 2025-02-28 | 16,819,686 | -9.1% | 7,720,691 | 2.18 |
| 2025-02-14 | 18,500,785 | -8.6% | 3,958,360 | 4.67 |
| 2025-01-31 | 20,237,578 | -19.9% | 6,217,052 | 3.26 |
| 2025-01-15 | 25,252,342 | -9.0% | 4,618,745 | 5.47 |
| 2024-12-31 | 27,756,496 | -6.8% | 3,121,583 | 8.89 |
| 2024-12-13 | 29,789,618 | -6.7% | 3,250,363 | 9.17 |
| 2024-11-29 | 31,937,565 | +5.1% | 3,783,765 | 8.44 |
| 2024-11-15 | 30,391,004 | -16.1% | 6,278,909 | 4.84 |
| 2024-10-31 | 36,223,247 | +1.0% | 3,856,563 | 9.39 |
| 2024-10-15 | 35,880,484 | -1.7% | 4,740,659 | 7.57 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 23 October 2026, the short share of AGL volume is 68.4%, up 8.3 points over the last five sessions. Over the last 30 readings it ranged from 34.4% (22 September 2026) to 81.0% (7 October 2026). The latest reading is 8.5 points above the 30-session average of 59.9%, on 80K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-23 | 55K | 80K | 68.4% | 75 |
| 2026-10-22 | 47K | 85K | 55.9% | 0 |
| 2026-10-21 | 45K | 76K | 59.9% | 0 |
| 2026-10-20 | 42K | 71K | 58.6% | 0 |
| 2026-10-19 | 50K | 71K | 70.1% | 0 |
| 2026-10-16 | 25K | 42K | 60.0% | 0 |
| 2026-10-15 | 37K | 52K | 70.5% | 0 |
| 2026-10-14 | 29K | 44K | 65.0% | 0 |
| 2026-10-13 | 33K | 48K | 68.7% | 0 |
| 2026-10-12 | 43K | 63K | 67.3% | 0 |
| 2026-10-09 | 42K | 60K | 69.7% | 0 |
| 2026-10-08 | 29K | 46K | 63.0% | 0 |
| 2026-10-07 | 64K | 79K | 81.0% | 0 |
| 2026-10-06 | 42K | 60K | 70.5% | 0 |
| 2026-10-05 | 37K | 56K | 66.8% | 0 |
| 2026-10-02 | 38K | 71K | 53.5% | 0 |
| 2026-10-01 | 62K | 86K | 72.7% | 0 |
| 2026-09-30 | 47K | 64K | 73.8% | 0 |
| 2026-09-29 | 43K | 66K | 65.1% | 0 |
| 2026-09-28 | 43K | 81K | 53.1% | 0 |
| 2026-09-25 | 89K | 128K | 69.8% | 1,657 |
| 2026-09-24 | 88K | 157K | 56.4% | 4,641 |
| 2026-09-23 | 31K | 78K | 40.3% | 0 |
| 2026-09-22 | 35K | 102K | 34.4% | 0 |
| 2026-09-21 | 28K | 65K | 44.1% | 10 |
| 2026-09-18 | 26K | 71K | 36.1% | 0 |
| 2026-09-17 | 37K | 80K | 46.4% | 0 |
| 2026-09-16 | 25K | 67K | 38.0% | 0 |
| 2026-09-15 | 47K | 76K | 62.1% | 41 |
| 2026-09-14 | 26K | 47K | 55.8% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 30 September 2026, the fails-to-deliver balance in AGL is 8 shares, down 169 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (15 May 2026) to 46,327 shares (25 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-30 | 8 | $78.15 | $625 |
| 2026-09-24 | 177 | $84.56 | $15K |
| 2026-09-18 | 1,070 | $89.17 | $95K |
| 2026-08-14 | 129 | $88.90 | $11K |
| 2026-08-04 | 4 | $94.11 | $376 |
| 2026-08-03 | 1,062 | $91.61 | $97K |
| 2026-07-30 | 28 | $92.66 | $3K |
| 2026-07-24 | 288 | $100.27 | $29K |
| 2026-07-22 | 616 | $125.78 | $77K |
| 2026-07-20 | 827 | $129.84 | $107K |
| 2026-07-17 | 10 | $121.22 | $1K |
| 2026-06-30 | 25 | $115.15 | $3K |
| 2026-06-29 | 199 | $119.25 | $24K |
| 2026-06-26 | 15 | $107.25 | $2K |
| 2026-06-25 | 46,327 | $106.96 | $5.0M |
| 2026-06-22 | 100 | $113.80 | $11K |
| 2026-06-17 | 400 | $113.27 | $45K |
| 2026-06-15 | 74 | $112.91 | $8K |
| 2026-06-12 | 84 | $116.16 | $10K |
| 2026-06-11 | 118 | $101.70 | $12K |
| 2026-06-05 | 564 | $95.23 | $54K |
| 2026-05-26 | 64 | $86.39 | $6K |
| 2026-05-19 | 669 | $86.80 | $58K |
| 2026-05-18 | 30 | $81.73 | $2K |
| 2026-05-15 | 1 | $78.49 | $78 |
| 2026-05-14 | 42 | $72.01 | $3K |
| 2026-05-13 | 41 | $69.54 | $3K |
| 2026-05-12 | 1,841 | $59.61 | $110K |
| 2026-05-08 | 10,360 | $60.66 | $628K |
| 2026-05-07 | 40 | $27.85 | $1K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for AGL in the last 90 days. The most recent filings are listed below. Latest filing: Gertsch Timothy (Chief Accounting Officer) on 2026-08-16.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-16 | Gertsch Timothy | Chief Accounting Officer | Tax withholding | 17 | $96.90 | $2K | 14K |
| 2026-08-01 | Zamore Denise | Chief Legal Officer | Tax withholding | 37 | $91.61 | $3K | 66K |
| 2026-07-01 | Schwaneke Jeffrey A. | Chief Financial Officer | Tax withholding | 2K | $111.74 | $258K | 138K |
| 2026-06-02 | Wulf John William | Director | Grant | 2K | $0.00 | $0 | 17K |
| 2026-06-02 | WILLIAMS RONALD A | Director | Grant | 2K | $0.00 | $0 | 149K |
| 2026-06-02 | McLoughlin Karen | Director | Grant | 2K | $0.00 | $0 | 8K |
| 2026-06-02 | Mansukani Sharad | Director | Grant | 2K | $0.00 | $0 | 56K |
| 2026-06-02 | MCKENZIE DIANA | Director | Grant | 2K | $0.00 | $0 | 8K |
| 2026-06-02 | Battaglia Silvana | Director | Grant | 2K | $0.00 | $0 | 8K |
| 2026-06-01 | Zamore Denise | Chief Legal Officer | Tax withholding | 485 | $92.54 | $45K | 66K |
| 2026-05-24 | Gertsch Timothy | Chief Accounting Officer | Tax withholding | 8 | $86.39 | $691 | 14K |
| 2026-05-07 | O'Rourke Timothy Patrick | CEO & President | Grant | 200K | $0.00 | $0 | 320K |
| 2026-05-07 | O'Rourke Timothy Patrick | CEO & President | Grant | 120K | $0.00 | $0 | 120K |
| 2026-04-15 | Zamore Denise | Chief Legal Officer | Tax withholding | 220 | $26.88 | $6K | 67K |
| 2026-04-15 | Venkatachaliah Girish | Chief Technology Officer | Tax withholding | 330 | $26.88 | $9K | 38K |
| 2026-04-15 | Shaker Benjamin | Chief Markets Officer | Tax withholding | 571 | $26.88 | $15K | 123K |
| 2026-04-15 | Gertsch Timothy | Chief Accounting Officer | Tax withholding | 122 | $26.88 | $3K | 14K |
| 2026-04-14 | Zamore Denise | Chief Legal Officer | Tax withholding | 20 | $22.68 | $454 | 67K |
| 2026-04-14 | Venkatachaliah Girish | Chief Technology Officer | Tax withholding | 96 | $22.68 | $2K | 39K |
| 2026-04-14 | Shaker Benjamin | Chief Markets Officer | Tax withholding | 104 | $22.68 | $2K | 123K |
| 2026-04-14 | Gertsch Timothy | Chief Accounting Officer | Tax withholding | 25 | $22.68 | $567 | 14K |
| 2026-04-01 | Zamore Denise | Chief Legal Officer | Grant | 50K | $0.00 | $0 | 67K |
| 2026-04-01 | Zamore Denise | Chief Legal Officer | Tax withholding | 1K | $9.75 | $10K | 17K |
| 2026-04-01 | Venkatachaliah Girish | Chief Technology Officer | Grant | 28K | $0.00 | $0 | 39K |
| 2026-04-01 | Venkatachaliah Girish | Chief Technology Officer | Tax withholding | 480 | $9.75 | $5K | 11K |
| 2026-04-01 | Shaker Benjamin | Chief Markets Officer | Grant | 70K | $0.00 | $0 | 124K |
| 2026-04-01 | Shaker Benjamin | Chief Markets Officer | Tax withholding | 2K | $9.75 | $16K | 54K |
| 2026-04-01 | Schwaneke Jeffrey A. | Chief Financial Officer | Grant | 75K | $0.00 | $0 | 140K |
| 2026-04-01 | Schwaneke Jeffrey A. | Chief Financial Officer | Tax withholding | 2K | $9.75 | $16K | 65K |
| 2026-04-01 | Gertsch Timothy | Chief Accounting Officer | Grant | 10K | $0.00 | $0 | 14K |
| 2026-04-01 | Gertsch Timothy | Chief Accounting Officer | Tax withholding | 266 | $9.75 | $3K | 4K |
| 2026-03-09 | Shaker Benjamin | Chief Markets Officer | Tax withholding | 6K | $0.60 | $4K | 1.4M |
| 2026-03-09 | Shaker Benjamin | Chief Markets Officer | Buy | 18K | price not stated in the filing | not stated | 1.4M |
| 2026-03-09 | Venkatachaliah Girish | Chief Technology Officer | Buy | 18K | price not stated in the filing | not stated | 285K |
| 2026-03-09 | Venkatachaliah Girish | Chief Technology Officer | Tax withholding | 6K | $0.60 | $4K | 279K |
| 2026-03-09 | Zamore Denise | Chief Legal Officer | Tax withholding | 2K | $0.60 | $1K | 447K |
| 2026-03-09 | Zamore Denise | Chief Legal Officer | Buy | 6K | price not stated in the filing | not stated | 449K |
| 2026-03-02 | Shaker Benjamin | Chief Markets Officer | Buy | 500K | $0.60 | $301K | 1.4M |
| 2026-01-10 | Schwaneke Jeffrey A. | Chief Financial Officer | Grant | 600K | $0.00 | $0 | 1.7M |
| 2025-11-12 | Wulf John William | Director | Buy | 81K | $0.63 | $51K | 366K |
| 2025-08-16 | Gertsch Timothy | Chief Accounting Officer | Tax withholding | 406 | $1.11 | $451 | 115K |
| 2025-08-01 | Zamore Denise | Chief Legal Officer | Tax withholding | 915 | $1.70 | $2K | 443K |
| 2025-07-01 | Schwaneke Jeffrey A. | Chief Financial Officer | Tax withholding | 46K | $2.38 | $110K | 1.1M |
| 2025-05-28 | Battaglia Silvana | Director | Grant | 79K | $0.00 | $0 | 145K |
| 2025-05-28 | Mansukani Sharad | Director | Grant | 79K | $0.00 | $0 | 1.4M |
| 2025-05-28 | McLoughlin Karen | Director | Grant | 79K | $0.00 | $0 | 152K |
| 2025-05-28 | WILLIAMS RONALD A | Director | Grant | 79K | $0.00 | $0 | 3.7M |
| 2025-05-28 | Wulf John William | Director | Grant | 79K | $0.00 | $0 | 285K |
| 2025-05-28 | MCKENZIE DIANA | Director | Grant | 79K | $0.00 | $0 | 138K |
| 2025-05-28 | Schwaneke Jeffrey A. | Chief Financial Officer | Tax withholding | 9K | $2.35 | $22K | 1.1M |
| 2025-05-24 | Gertsch Timothy | Chief Accounting Officer | Tax withholding | 193 | $2.22 | $428 | 115K |
| 2025-04-15 | Venkatachaliah Girish | Chief Technology Officer | Tax withholding | 8K | $5.53 | $45K | 267K |
| 2025-04-15 | Zamore Denise | Chief Legal Officer | Tax withholding | 5K | $5.53 | $30K | 444K |
| 2025-04-15 | Gertsch Timothy | Chief Accounting Officer | Tax withholding | 3K | $5.53 | $17K | 115K |
| 2025-04-15 | Shaker Benjamin | Chief Markets Officer | Tax withholding | 15K | $5.53 | $81K | 868K |
| 2025-04-15 | Sell Steven | CEO & President | Tax withholding | 23K | $5.53 | $125K | 862K |
| 2025-04-14 | Venkatachaliah Girish | Chief Technology Officer | Tax withholding | 3K | $5.60 | $16K | 275K |
| 2025-04-14 | Zamore Denise | Chief Legal Officer | Tax withholding | 517 | $5.60 | $3K | 450K |
| 2025-04-14 | Gertsch Timothy | Chief Accounting Officer | Tax withholding | 662 | $5.60 | $4K | 118K |
| 2025-04-14 | Shaker Benjamin | Chief Markets Officer | Tax withholding | 4K | $5.60 | $21K | 882K |
| 2025-04-14 | Sell Steven | CEO & President | Tax withholding | 8K | $5.60 | $44K | 885K |
| 2025-04-01 | Sell Steven | CEO & President | Grant | 551K | $0.00 | $0 | 907K |
| 2025-04-01 | Gertsch Timothy | Chief Accounting Officer | Grant | 61K | $0.00 | $0 | 119K |
| 2025-04-01 | Shaker Benjamin | Chief Markets Officer | Grant | 429K | $0.00 | $0 | 886K |
| 2025-04-01 | Venkatachaliah Girish | Chief Technology Officer | Grant | 123K | $0.00 | $0 | 278K |
| 2025-04-01 | Zamore Denise | Chief Legal Officer | Grant | 245K | $0.00 | $0 | 450K |
| 2025-04-01 | Schwaneke Jeffrey A. | Chief Financial Officer | Grant | 429K | $0.00 | $0 | 1.1M |
| 2025-03-14 | Venkatachaliah Girish | Chief Technology Officer | Tax withholding | 3K | $4.05 | $13K | 155K |
| 2025-03-14 | Venkatachaliah Girish | Chief Technology Officer | Buy | 9K | price not stated in the filing | not stated | 158K |
| 2025-03-14 | Shaker Benjamin | Chief Markets Officer | Buy | 12K | price not stated in the filing | not stated | 461K |
| 2025-03-14 | Shaker Benjamin | Chief Markets Officer | Tax withholding | 4K | $4.05 | $17K | 457K |
| 2025-03-14 | Sell Steven | CEO & President | Tax withholding | 16K | $4.05 | $63K | 355K |
| 2025-03-14 | Sell Steven | CEO & President | Buy | 42K | price not stated in the filing | not stated | 371K |
| 2024-12-13 | McLoughlin Karen | Director | Buy | 25K | $2.20 | $55K | 73K |
| 2024-12-11 | Battaglia Silvana | Director | Buy | 25K | $2.01 | $50K | 66K |
| 2024-12-09 | MCKENZIE DIANA | Director | Buy | 8K | $2.20 | $17K | 59K |
| 2024-12-05 | Wulf John William | Director | Buy | 45K | $2.18 | $98K | 206K |
| 2024-11-25 | MCKENZIE DIANA | Director | Buy | 13K | $2.28 | $29K | 51K |
| 2024-09-12 | Sell Steven | CEO & President | Buy | 20K | $3.36 | $67K | 68K |
| 2024-08-16 | Gertsch Timothy | Chief Accounting Officer | Tax withholding | 405 | $4.85 | $2K | 58K |
| 2024-07-01 | Schwaneke Jeffrey A. | Chief Financial Officer | Grant | 132K | $0.00 | $0 | 573K |
| 2024-07-01 | Schwaneke Jeffrey A. | Chief Financial Officer | Grant | 377K | $0.00 | $0 | 441K |
| 2024-07-01 | Schwaneke Jeffrey A. | Chief Financial Officer | Grant | 151K | $0.00 | $0 | 724K |
| 2024-05-29 | Battaglia Silvana | Director | Grant | 32K | $0.00 | $0 | 41K |
| 2024-05-29 | Mansukani Sharad | Director | Grant | 32K | $0.00 | $0 | 1.3M |
| 2024-05-29 | Schwaneke Jeffrey A. | Director | Grant | 32K | $0.00 | $0 | 64K |
| 2024-05-29 | Wulf John William | Director | Grant | 32K | $0.00 | $0 | 161K |
| 2024-05-29 | McLoughlin Karen | Director | Grant | 32K | $0.00 | $0 | 48K |
| 2024-05-29 | MCKENZIE DIANA | Director | Grant | 32K | $0.00 | $0 | 39K |
| 2024-05-29 | WILLIAMS RONALD A | Director | Grant | 32K | $0.00 | $0 | 3.6M |
| 2024-05-24 | Gertsch Timothy | Chief Accounting Officer | Tax withholding | 187 | $6.09 | $1K | 58K |
| 2024-04-15 | Sell Steven | CEO & President | Grant | 252K | $0.00 | $0 | 336K |
| 2024-04-15 | Desai Veeral | Chief Strategy & Dev. Officer | Grant | 196K | $0.00 | $0 | 503K |
| 2024-04-15 | Shaker Benjamin | Chief Markets Officer | Grant | 196K | $0.00 | $0 | 455K |
| 2024-04-15 | Venkatachaliah Girish | Chief Technology Officer | Grant | 112K | $0.00 | $0 | 152K |
| 2024-04-15 | Gertsch Timothy | Chief Accounting Officer | Grant | 42K | $0.00 | $0 | 59K |
| 2024-04-14 | Sell Steven | CEO & President | Tax withholding | 8K | $4.95 | $39K | 328K |
| 2024-04-14 | Desai Veeral | Chief Strategy & Dev. Officer | Tax withholding | 5K | $4.95 | $24K | 498K |
| 2024-04-14 | Shaker Benjamin | Chief Markets Officer | Tax withholding | 6K | $4.95 | $27K | 449K |
| 2024-04-14 | Venkatachaliah Girish | Chief Technology Officer | Tax withholding | 3K | $4.95 | $15K | 149K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON4 holders report 5% or more of AGL in their latest filing, all on Schedule 13G (passive). The largest reported stake is North Peak Capital Management, LLC at 9.5% of the class (39,411,957 shares), filed 2025-11-13 for an event on 2025-09-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-12 | 13G/Ano. 1 | AQR Capital Management, LLCinvestment adviser | 693K | 4.2% | 2026-06-30 |
| 2026-08-12 | 13G/Ano. 1 | AQR Capital Management Holdings, LLCparent holding company | 693K | 4.2% | 2026-06-30 |
| 2026-08-11 | 13G/Ano. 1 | THE GOLDMAN SACHS GROUP, INC.parent holding company, corporation | 652K | 3.9% | 2026-06-30 |
| 2026-08-11 | 13G/Ano. 1 | GOLDMAN SACHS & CO. LLCbroker-dealer, other entity, investment adviser | 652K | 3.9% | 2026-06-30 |
| 2026-01-30 | 13G/Ano. 2 | The Vanguard Groupinvestment adviser | 18.3M | 4.4% | 2025-12-31 |
| 2025-11-13 | 13G/Ano. 1 | North Peak Capital Management, LLCinvestment adviser, other entity | 39.4M | 9.5% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | North Peak Capital GP, LLCother entity | 32.0M | 7.7% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | Michael Kevin Kahanparent holding company, individual | 32.0M | 7.7% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | Jeremy Steven Kahanparent holding company, corporation | 32.0M | 7.7% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | North Peak Capital Partners II, LPpartnership | 18.4M | 4.4% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | North Peak Capital Alpha Fund, LPpartnership | 9.8M | 2.4% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | North Peak Capital Partners, LPpartnership | 2.2M | 0.5% | 2025-09-30 |
| 2025-11-13 | 13G/Ano. 1 | North Peak Capital Ultra Fund, LPpartnership | 1.6M | 0.4% | 2025-09-30 |
| 2025-11-05 | 13G/Ano. 1 | Abigail P. Johnsonindividual | 15.4M | 3.7% | 2025-09-30 |
| 2025-11-05 | 13G/Ano. 1 | FMR LLCparent holding company | 15.4M | 3.7% | 2025-09-30 |
13F holders
Tracked managers holding AGL at their latest 13F. JSON7 of the 30 tracked managers held AGL at their latest 13F, $159.0M in total at quarter-end prices. AQR Capital Management is the largest at $74.2M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 693K | $74.2M | 0.03% | -282K |
| D. E. Shaw & Co. | 2026-06-30 | 390K | $41.8M | 0.02% | -352K |
| Renaissance Technologies | 2026-06-30 | 152K | $16.3M | 0.02% | +3K |
| Two Sigma Investments | 2026-06-30 | 126K | $13.5M | 0.01% | +26K |
| Citadel Advisors | 2026-06-30 | 56K | $6.0M | 0.00% | new |
| Millennium Management | 2026-06-30 | 34K | $3.6M | 0.00% | new |
| Point72 Asset Management | 2026-06-30 | 33K | $3.5M | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) agilon health reported revenue of $1.49B, up 7.2% from the same quarter a year earlier, and net income of $18.0M (1.04 diluted EPS). In FY 2025 it generated -$105.8M of operating cash flow. As of 2026-06-30, cash was $107.2M against $15.4M of debt.
- Cash
- $107.2M
- Debt
- $15.4M
- Total assets
- $1.59B
- Shares outstanding
- 16,791,210
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $1.49B | $18.0M | 1.2% | 1.04 |
| Q1 FY 2026 | 2026-03-31 | $1.42B | $48.9M | 3.4% | 2.94 |
| Q4 FY 2025derived | 2025-12-31 | $1.57B | -$188.9M | -12.0% | n/a |
| Q3 FY 2025 | 2025-09-30 | $1.44B | -$110.2M | -7.7% | n/a |
| Q2 FY 2025 | 2025-06-30 | $1.39B | -$104.4M | -7.5% | -6.31 |
| Q1 FY 2025 | 2025-03-31 | $1.53B | $12.1M | 0.8% | 0.73 |
| Q4 FY 2024derived | 2024-12-31 | $1.52B | -$105.8M | -6.9% | n/a |
| Q3 FY 2024 | 2024-09-30 | $1.45B | -$117.6M | -8.1% | n/a |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5.93B | -$391.3M | -$105.8M | $13.2M | n/a | n/a |
| FY 2024 | 2024-12-31 | $6.06B | -$260.2M | -$57.8M | $13.3M | n/a | n/a |
| FY 2023 | 2023-12-31 | $4.32B | -$262.6M | -$156.2M | $15.8M | $200.0M | n/a |
| FY 2022 | 2022-12-31 | $2.39B | -$106.6M | -$130.8M | $15.4M | n/a | n/a |
| FY 2021 | 2021-12-31 | $1.52B | -$406.5M | -$148.2M | $6.6M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-30 from the cover page.
What this page is
agilon health in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows agilon health (AGL), SEC CIK 1831097, listed on NYSE, classified by the SEC as services-misc health & allied services, nec. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-30.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-12.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-16.JSON and CSV
- Company record
- EDGAR filing index for CIK 1831097Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-misc health & allied services, nec
Other company pages
Datasets
Frequently Asked Questions
How much of AGL is sold short?
1,008,702 shares were held short at the 2026-09-30 settlement, 3.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is AGL's daily short volume?
On 2026-10-23, 54,517 of the 79,744 AGL shares reported to FINRA were sold short, 68.4% of the day's reported volume. Short volume is a flow for one day, not a position.
Does AGL have fails to deliver?
The SEC's latest file shows 8 AGL shares failed to deliver at settlement 2026-09-30. Fails are reported per settlement date and published twice a month with a lag.
Are AGL insiders buying or selling?
No open-market insider trades were reported for AGL in the last 90 days. The most recent filings are listed below. Latest filing: Gertsch Timothy (Chief Accounting Officer) on 2026-08-16.
Who owns 5% or more of AGL?
4 holders report 5% or more of AGL in their latest filing, all on Schedule 13G (passive). The largest reported stake is North Peak Capital Management, LLC at 9.5% of the class (39,411,957 shares), filed 2025-11-13 for an event on 2025-09-30.
What did AGL report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) agilon health reported revenue of $1.49B, up 7.2% from the same quarter a year earlier, and net income of $18.0M (1.04 diluted EPS). In FY 2025 it generated -$105.8M of operating cash flow. As of 2026-06-30, cash was $107.2M against $15.4M of debt.
Which tracked 13F managers own AGL?
7 of the 30 tracked 13F managers held AGL shares at their latest filing, $159.0M in all. The largest: Cliff Asness's AQR Capital Management (693K shares, $74.2M), D. E. Shaw & Co. (390K shares, $41.8M), Renaissance Technologies (152K shares, $16.3M), Two Sigma Investments (126K shares, $13.5M), Ken Griffin's Citadel Advisors (56K shares, $6.0M), Izzy Englander's Millennium Management (34K shares, $3.6M). The table above lists all 7.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.